ResearcherThe Royal Free HospitalNo recent work listed
Giuseppe Preziosi
Matched on ORCID iD 0000-0001-5739-3675; OpenAlex author ID A5051379831. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper
Papers 3
- Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic cancer. Co-author DOI 10.1002/bjs.10580↗
- Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection for Pancreatic Cancer Study Group. Co-author DOI 10.1016/j.ejso.2015.08.158↗
- Obesity and pancreatic cancer. Co-author DOI 10.1016/j.suronc.2014.02.003↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Giuseppe Fusai · 3 shared papers, 2014–2017 · strength 0.16
- Paper Obesity and pancreatic cancer. DOI 10.1016/j.suronc.2014.02.003↗
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- Charles J. Imber · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- R. Ravikumar · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- Steven Alan White · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- Stephen J. Wigmore · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- Somaiah Aroori · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- David A. Stell · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- Mohammad Abu Hilal · 2 shared papers, 2015–2017 · strength 0.09
- Paper Impact of portal vein infiltration and type of venous reconstruction in surgery for borderline resectable pancreatic ca… DOI 10.1002/bjs.10580↗
- Paper Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection fo… DOI 10.1016/j.ejso.2015.08.158↗
- Hassan Elberm · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.